BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 18557390)

  • 1. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
    Delvenne P
    Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination against HPV in adults].
    Gil Á
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
    [No Abstract]   [Full Text] [Related]  

  • 6. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts.
    Wright TC; Bosch FX; Franco EL; Cuzick J; Schiller JT; Garnett GP; Meheus A
    Vaccine; 2006 Aug; 24 Suppl 3():S3/251-61. PubMed ID: 16950014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women.
    Bhatla N; Suri V; Basu P; Shastri S; Datta SK; Bi D; Descamps DJ; Bock HL;
    J Obstet Gynaecol Res; 2010 Feb; 36(1):123-32. PubMed ID: 20178538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for cervical cancer prevention by human papillomavirus vaccination.
    Schiller JT; Lowy DR
    Cancer Res; 2006 Nov; 66(21):10229-32. PubMed ID: 17079437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cervical cancer through vaccination of adolescents.
    Pichichero ME
    Clin Pediatr (Phila); 2006 Jun; 45(5):393-8. PubMed ID: 16891270
    [No Abstract]   [Full Text] [Related]  

  • 11. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
    Franco EL; Cuzick J; Hildesheim A; de Sanjosé S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
    Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
    Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
    ; Collins Y; Einstein MH; Gostout BS; Herzog TJ; Massad LS; Rader JS; Wright J
    Gynecol Oncol; 2006 Sep; 102(3):552-62. PubMed ID: 16979432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening: Testing times.
    Humphries C
    Nature; 2012 Aug; 488(7413):S8-9. PubMed ID: 22932440
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine: a randomized, controlled trial in adolescent girls.
    Medina DM; Valencia A; de Velasquez A; Huang LM; Prymula R; García-Sicilia J; Rombo L; David MP; Descamps D; Hardt K; Dubin G;
    J Adolesc Health; 2010 May; 46(5):414-21. PubMed ID: 20413076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: an Australian perspective.
    Farnsworth A
    Acta Cytol; 2011; 55(4):307-12. PubMed ID: 21791898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccines: state of the art.
    D'Andrilli G; Bovicelli A; Giordano A
    J Cell Physiol; 2010 Sep; 224(3):601-4. PubMed ID: 20432468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV-vaccine and screening programs: the new era of global prevention.
    Mariani L
    J Prev Med Hyg; 2009 Jun; 50(2):90-5. PubMed ID: 20099438
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening.
    Giorgi Rossi P; Zorzi M
    Acta Obstet Gynecol Scand; 2010 Jun; 89(6):846-7; author reply 848. PubMed ID: 20504086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.